The U.S. Food and Drug Administration recently expanded approval of Addyi, a daily pill for low sex drive, to postmenopausal women up to age 65. This change could reach millions more women but faces ...
The FDA expanded its approval of Addyi, a pill to treat low libido in women, to include postmenopausal women up to age 65. The approval will open up new treatment options for older women, but experts ...
The FDA has approved Addyi (flibanserin), a nonhormonal daily pill, to treat low libido in women through age 65. The FDA previously approved Addyi for low sex drive in younger women. Addyi carries a ...
WASHINGTON — U.S. health officials have expanded approval of a much-debated drug aimed at boosting female libido, saying the once-a-day pill can now be taken by postmenopausal women up to 65 years old ...
More than a decade ago, Addyi—marketed as the “female Viagra”—was approved amid political pressure, heavy lobbying, and a lot ...
PHIL expands direct-to-patient access to Addyi for as low as $40 per year with commercial insurance coverage or $149 per month cash whether accessed through telehealth or a doctor's office.SCOTTSDALE, ...
FILE - In this Aug. 18, 2015 file photo, Sprout Pharmaceuticals CEO Cindy Whitehead holds a bottle for the female sex-drive drug Addyi in Raleigh, N.C. (AP Photo/Allen G. Breed, File) FILE - In this ...